Jonathan Friedberg
Onco
Daily
Facebook
RSS
X
Youtube
Linkedin
October, 2024
October 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Sep
Jonathan Friedberg
Oct 19, 2024, 16:52 |
Blog
9 out of 10 patients who got the immunotherapy for Hodgkin Lymphoma were in remission after two years - Wilmot Cancer Institute
Wilmot Cancer Institute recently posted on LinkedIn: “Exciting news! A new study just published in…
Oct 18, 2024, 16:33 |
Blog
Jonathan Friedberg: End Point Surrogacy in First-Line CLL
Jonathan Friedberg, Director of Wilmot Cancer Institute, posted the following on X: “End Point Surrogacy in…
Aug 11, 2024, 10:29 |
Blog
The intratumoral microbiome in lung cancer
Sumanta K. Pal shared a post on X: "HUGE congrats to Arielle Elkrief, Smruthy Sivakumar, Marc…
May 17, 2024, 15:25 |
Blog
Andrea Necchi: Profoundly honored to serve as new Associate Editor Journal of Clinical Oncology
Andrea Necchi, Associate Professor of Oncology at Vita-Salute San Raffaele University, shared a post on…
Dec 23, 2023, 15:58 |
Blog
Vivek Subbiah: Here's to four decades of impactful research!
Vivek Subbiah shared on X/Twitter: "Milestone alert! Celebrating Journal of Clinical Oncology's 40th anniversary. Huge…
All:
5
Posts:
1 - 100
Making Personal Experience a Political Priority: Insights from EU Commissioner Stella Kyriakides
Zolbetuximab is now approved by the US FDA
Highlights from NFCR’s GSAC24
SIOP Honoured Hansjörg Riehm with the 2024 Lifetime Achievement Award
Margaret Foti has received the 2024 Beacon Award for Women Leaders in Oncology
Special Coverage
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Facebook
RSS Feed
X
Linkedin
Youtube